Positron Emission Tomography News and Research

RSS

Novel MRI contrast agent offers hope for early detection of Alzheimer’s disease

Hong Kong Baptist University scientists have invented a novel contrast agent for magnetic resonance imaging, which enables real-time visualization and detection of the size and number of amyloid-beta in the brain, a main hallmark of Alzheimer’s disease.

2 Nov 2020

Researchers validate new radiolabeled molecule used in imaging tests to detect brain injury

Researchers have validated a new radiolabeled molecule that can be used with imaging tests to accurately detect and characterize brain injury.

22 Oct 2020

Brain metabolic changes associated with loss of smell in COVID-19

A recent study detailed in a preprint paper published in medRxiv, researchers from Belgium, discuss how they investigated possible central nervous system (CNS) involvement in COVID-19 patients with a sudden loss of smell using a hybrid positron emission tomography (PET)-magnetic resonance imaging (MRI) system (PET-MR).

21 Oct 2020

Anti-inflammatory therapy helps slow progression of multiple sclerosis in a preclinical model

Intranasal administration of an anti-inflammatory drug helped reduce disease progression in a preclinical model of multiple sclerosis, according to recent research out of the University of Alberta.

20 Oct 2020

New tool can provide non-invasive decision support for NSCLC treatment

Personalized treatment options for patients with lung cancer have come a long way in the past two decades.

16 Oct 2020

Qualitative review sheds light on AI development for treatment of brain diseases

The range of AI technologies available for dealing with brain disease is growing fast, and exciting new methods are being applied to brain problems as computer scientists gain a deeper understanding of the capabilities of advanced algorithms.

14 Oct 2020

BioChromato's Smart Evaporator C1 offers safe, efficient concentration of low volume samples

BioChromato Inc. reports how the Department of Bioimaging Information Analysis at Gunma University is benefiting from the ability of its Smart Evaporator C1 to safely and efficiently concentrate low volume samples.

From BioChromato Inc. 9 Oct 2020

Cerenkov luminescence imaging can accurately assess surgical margins during radical prostatectomy

A new intraoperative imaging technique, Cerenkov luminescence imaging (CLI), can accurately assess surgical margins during radical prostatectomy, according to a first-in-human research published in the October issue of the Journal of Nuclear Medicine.

7 Oct 2020

New upgrade to PET scanners may pave way for better cancer treatment

Experts in Japan have devised a simple way to glean more detailed information out of standard medical imaging scans.

1 Oct 2020

Late-life depression not linked with increased amyloid deposits in the brain

Depression in elderly people can include symptoms such as memory loss, making it hard to distinguish from the early stages of Alzheimer's disease and other types of dementia.

23 Sep 2020

Innovative approach for identifying new molecules to help track progression of Parkinson's

For many of the 200,000 patients diagnosed with Parkinson's disease in the United States every year, the diagnosis often occurs only after the appearance of severe symptoms such as tremors or speech difficulties.

21 Sep 2020

Molecular imaging probe reveals Alzheimer's-related γ-secretase in rodents, macaques

Scientists at the Massachusetts General Hospital (MGH) have developed a molecular imaging probe to reveal Alzheimer's disease (AD)-related γ-secretase in rodents and macaques with translational potentials in humans.

18 Sep 2020

PET/MRI reduces radiation exposure, improves lesion detectability in select cancers

A single-center observational study of more than 1,000 oncological examinations has demonstrated that positron emission tomography/magnetic resonance imaging (PET/MRI) facilitates cancer staging as well as PET/computed tomography (PET/CT) and improves lesion detectability in select cancers, potentially helping to promote fast, efficient local and whole-body staging in one step.

17 Sep 2020

New nanomedicine is efficient and less aggressive than conventional prostate cancer therapy

Prostate cancer is the most common type of cancer among European men; its incidence surpasses 100 cases per 100,000 people.

15 Sep 2020

NIH provides additional support for large scale study of Alzheimer's disease biomarkers

To meet the pressing need to better understand the prevalence, progression, and clinical impact of Alzheimer's disease among Mexican Americans, the National Institutes of Health has added funding for more biomarker measures, including positron emission tomography imaging, to the ongoing Health and Aging Brain Among Latino Elders Study.

14 Sep 2020

Molecular imaging reveals ASD-related brain differences

People with autism spectrum disorder have lower levels of a protein that regulates the amount of serotonin in the brain, a paper from Karolinska Institutet in Sweden published in the journal Molecular Psychiatry reports.

9 Sep 2020

Sleep may serve as a marker of Alzheimer’s disease risk and progression

What would you do if you knew how long you had until Alzheimer's disease set in? Don't despair. New research from the University of California, Berkeley, suggests one defense against this virulent form of dementia -- for which no treatment currently exists -- is deep, restorative sleep, and plenty of it.

3 Sep 2020